RNA transcription vector and uses thereof

The present invention in general relates to an improved RNA transcription vector, which is very suitable for the production of mRNA for in vivo therapeutic purposes. The improvements in the vector in particular reside in the presence of a transcription enhancer and a nuclear retention element.

Patent Publication Number: US10864284

Year filing: 2020

Year approval: 2020

Validated for IOF-key: Yes

Attributed to: Universitaire Associatie Brussel